Literature DB >> 15121872

Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.

Jason H Kurzer1, Lawrence S Argetsinger, Yong-Jie Zhou, Jean-Louis K Kouadio, John J O'Shea, Christin Carter-Su.   

Abstract

The tyrosine kinase Janus kinase 2 (JAK2) binds to the majority of the known members of the cytokine family of receptors. Ligand-receptor binding leads to activation of the associated JAK2 molecules, resulting in rapid autophosphorylation of multiple tyrosines within JAK2. Phosphotyrosines can then serve as docking sites for downstream JAK2 signaling molecules. Despite the importance of these phosphotyrosines in JAK2 function, only a few sites and binding partners have been identified. Using two-dimensional phosphopeptide mapping and a phosphospecific antibody, we identified tyrosine 813 as a site of JAK2 autophosphorylation of overexpressed JAK2 and endogenous JAK2 activated by growth hormone. Tyrosine 813 is contained within a YXXL sequence motif associated with several other identified JAK2 phosphorylation sites. We show that phosphorylation of tyrosine 813 is required for the SH2 domain-containing adapter protein SH2-B beta to bind JAK2 and to enhance the activity of JAK2 and STAT5B. The homologous tyrosine in JAK3, tyrosine 785, is autophosphorylated in response to interleukin-2 stimulation and is required for SH2-B beta to bind JAK3. Taken together these data strongly suggest that tyrosine 813 is a site of autophosphorylation in JAK2 and is the SH2-B beta-binding site within JAK2 that is required for SH2-B beta to enhance activation of JAK2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121872      PMCID: PMC400461          DOI: 10.1128/MCB.24.10.4557-4570.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

Review 1.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  A road map for those who don't know JAK-STAT.

Authors:  David S Aaronson; Curt M Horvath
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

3.  SH2-B family members differentially regulate JAK family tyrosine kinases.

Authors:  Karen B O'Brien; John J O'Shea; Christin Carter-Su
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

4.  Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation.

Authors:  Monica Kong; Ching S Wang; Daniel J Donoghue
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

Review 5.  The Jak/STAT pathway in model organisms: emerging roles in cell movement.

Authors:  Steven X Hou; Zhiyu Zheng; Xiu Chen; Norbert Perrimon
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

6.  Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein.

Authors:  Nick Carpino; Ryuji Kobayashi; Heesuk Zang; Yutaka Takahashi; Shiann-Tarrng Jou; Jian Feng; Hideaki Nakajima; James N Ihle
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

7.  Jak2 is involved in c-Myc induction by Bcr-Abl.

Authors:  Shanhai Xie; Hui Lin; Tong Sun; Ralph B Arlinghaus
Journal:  Oncogene       Date:  2002-10-17       Impact factor: 9.867

8.  APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.

Authors:  T Wakioka; A Sasaki; K Mitsui; M Yokouchi; A Inoue; S Komiya; A Yoshimura
Journal:  Leukemia       Date:  1999-05       Impact factor: 11.528

9.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.

Authors:  Alan Cheng; Noriko Uetani; Paul D Simoncic; Vikas P Chaubey; Ailsa Lee-Loy; C Jane McGlade; Brian P Kennedy; Michel L Tremblay
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

10.  YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.

Authors:  Karen B O'Brien; Lawrence S Argetsinger; Maria Diakonova; Christin Carter-Su
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

View more
  49 in total

1.  The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Authors:  Mojib Javadi; Edda Hofstätter; Natalie Stickle; Bryan K Beattie; Robert Jaster; Christin Carter-Su; Dwayne L Barber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Kinase activation through dimerization by human SH2-B.

Authors:  Masahiro Nishi; Eric D Werner; Byung-Chul Oh; J Daniel Frantz; Sirano Dhe-Paganon; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.

Authors:  Minghua Li; Zhiqin Li; David L Morris; Liangyou Rui
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

Review 4.  Therapeutic targeting of Janus kinases.

Authors:  Marko Pesu; Arian Laurence; Nandini Kishore; Samuel H Zwillich; Gary Chan; John J O'Shea
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 5.  Molecular and neural mediators of leptin action.

Authors:  Scott A Robertson; Gina M Leinninger; Martin G Myers
Journal:  Physiol Behav       Date:  2008-04-13

6.  Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.

Authors:  Sigal Gery; Qi Cao; Saskia Gueller; Hongtao Xing; Ayalew Tefferi; H Phillip Koeffler
Journal:  J Leukoc Biol       Date:  2009-03-17       Impact factor: 4.962

Review 7.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein.

Authors:  Erin E O'Leary; Anna M Mazurkiewicz-Muñoz; Lawrence S Argetsinger; Travis J Maures; Hung T Huynh; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2013-02-28

9.  AKT/eNOS signaling module functions as a potential feedback loop in the growth hormone signaling pathway.

Authors:  Cong-Jun Li; Theodore H Elsasser; Stanislaw Kahl
Journal:  J Mol Signal       Date:  2009-03-25

10.  Insufficiency of Janus kinase 2-autonomous leptin receptor signals for most physiologic leptin actions.

Authors:  Scott Robertson; Ryoko Ishida-Takahashi; Isao Tawara; Jiang Hu; Christa M Patterson; Justin C Jones; Rohit N Kulkarni; Martin G Myers
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.